Accreditation Under Specialty Pharmacy, Version 5.0 Program, Effective April 1, 2026
POMPANO BEACH, Fla., April 1, 2026 /PRNewswire/ — Patient Care America, a premier renal healthcare provider specializing in precision medicine nutrition support and clinical solutions for kidney disease patients, today announced that it has received Full URAC Accreditation under the Specialty Pharmacy, Version 5.0 Program, effective April 1, 2026. This achievement underscores PCA’s ongoing commitment to quality, safety, and patient-centered care.
“We are proud to receive Full URAC Accreditation, which reflects the dedication of our teams to providing exceptional care every day,” said Phil Keough, Chief Executive Officer of Patient Care America. “Importantly, this recognition validates the systems and processes we have built to consistently deliver high quality care and allows us to extend our infusion and specialty pharmacy services to more patients with chronic conditions who depend on specialized support.”
URAC accreditation is a nationally recognized, independent validation of a healthcare organization’s quality management and operational practices. Full Accreditation under the Specialty Pharmacy program indicates that Patient Care America meets rigorous standards related to clinical oversight, patient safety, consumer protections, and performance measurement.
“URAC accreditation affirms what matters most to us – putting patients at the center of everything we do,” said Karin Hehenberger, MD, PhD, Chief Medical Officer of Patient Care America. “For individuals navigating dialysis or life after transplant, consistency, safety, and trust in their pharmacy partner are critical. This achievement enhances our ability to support patients holistically while strengthening collaboration with providers and pharmaceutical partners to improve outcomes.”
The accreditation further strengthens Patient Care America’s position as a trusted partner for patients, providers, and payers nationwide, while reinforcing the organization’s commitment to continuous improvement and regulatory excellence.
About Patient Care America
Patient Care America (PCA) is a premier renal healthcare provider specializing in precision medicine nutrition support and clinical solutions for kidney disease patients. PCA offers evidence-based therapies such as IDPN (Intradialytic Parenteral Nutrition) and IPN (Intraperitoneal Nutrition) to help manage malnutrition and improve clinical outcomes. Backed by published research, its therapies are trusted by nephrology teams and dialysis clinics nationwide. PCA also offers bundled prescription medications, streamlining delivery and supporting improved medication adherence. PCA advances its commitment to supporting patients beyond the clinic with the patient empowerment tools delivered through its Lyfebulb platform.
About URAC
Founded in 1990 as a non-profit organization, URAC is the independent leader in promoting health care quality and patient safety through renowned accreditation programs. URAC develops its evidence-based standards in collaboration with a wide array of stakeholders and industry experts. The company’s portfolio of accreditation and certification programs spans the health care industry, addressing health equity, workplace mental health, health care management and operations, pharmacies, telehealth, health plans, medical practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.
View original content to download multimedia:https://www.prnewswire.com/news-releases/patient-care-america-receives-full-urac-accreditation-for-specialty-pharmacy-services-302728619.html
SOURCE Patient Care America
